CellaVision establishes subsidiary in Japan

27-Mar-2008

CellaVision, which develops and sells digital morphology products for the routine analysis of blood and other body fluids, has registered a subsidiary in Japan. Koichi Matsumoto has been appointed Representative Director.

"By establishing our own subsidiary in Japan we can effectively meet the demands on our products in the region. We look forward to be active on this potentially substantial market", says Yvonne Mårtensson.

The new subsidiary, CellaVision Japan K.K, will primarily prepare for sales by arranging for the licenses required for sales and support of Medtech products in Japan. The process is expected to come to completion during the third quarter this year. A small-sized sales organization will be set up during the year, with intentions of being operative when all licenses have been obtained.

Koichi Matsumoto most recently worked for Beckman Coulter in Japan. As Representative Director, Matsumoto will be responsible for sales of CellaVision's products to hematology laboratories in Japan. Matsumoto has several years of experience in sales of laboratory equipment to hospitals and private laboratories.

Other news from the department business & finance

Most read news

More news from our other portals

Fighting cancer: latest developments and advances